Structural Predictors of Lung Function Decline in Young Smokers with Normal Spirometry

被引:14
|
作者
Ritchie, Andrew I. [1 ,2 ]
Donaldson, Gavin C. [1 ]
Hoffman, Eric A. [3 ,4 ]
Allinson, James P. [1 ,5 ]
Bloom, Chloe I. [1 ]
Bolton, Charlotte E. [6 ,7 ,8 ]
Choudhury, Gourab [9 ]
Gerard, Sarah E. [4 ]
Guo, Junfeng
Alves-Moreira, Luana [1 ]
McGarvey, Lorcan [10 ,11 ]
Sapey, Elizabeth [12 ]
Stockley, Robert A. [12 ]
Yip, K. P. [12 ]
Singh, Dave [13 ]
Wilkinson, Tom [14 ,15 ]
Fageras, Malin [16 ]
Ostridge, Kristoffer [14 ,16 ]
Joens, Olaf [17 ]
Bucchioni, Enrica [18 ]
Compton, Chris H. [19 ]
Jones, Paul [19 ]
Mezzi, Karen [20 ]
Vestbo, Jorgen [13 ]
Calverley, Peter M. A. [21 ]
Wedzicha, Jadwiga A. [1 ]
机构
[1] Imperial Coll London, Natl Heart & Lung Inst, London, England
[2] AstraZeneca, Cambridge, England
[3] Univ Iowa, Dept Radiol, Iowa City, IA USA
[4] Univ Iowa, Roy J Carver Dept Biomed Engn Med & Biomed Engn, Iowa City, IA USA
[5] Royal Brompton Hosp, London, England
[6] Univ Nottingham, NIHR Nottingham Biomed Res Ctr, Nottingham, England
[7] Univ Nottingham, Ctr Resp Res, NIHR Nottingham, Translat Med Sci,Sch Med, Nottingham, England
[8] Queens Med Res Inst, ELEGI Labs, Edinburgh, Midlothian, Scotland
[9] Queens Med Res Inst, COLT Labs, Edinburgh, Midlothian, Scotland
[10] Queens Univ Belfast, Wellcome Wolfson Inst Expt Med, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland
[11] Belfast Hlth & Social Care Trust, Belfast, Antrim, North Ireland
[12] Univ Birmingham, Inst Inflammat & Ageing, Birmingham, W Midlands, England
[13] Univ Manchester, Div Infect Immun & Resp Med, Manchester, Lancs, England
[14] Univ Southampton, Fac Med, Southampton, Hants, England
[15] Southampton Univ Hosp, Natl Inst Hlth & Care Res, Southampton Biomed Res Ctr, Southampton, Hants, England
[16] AstraZeneca, Gothenburg, Sweden
[17] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[18] Chiesi Farmaceut SpA, Parma, Italy
[19] GlaxoSmithKline, Brentford, England
[20] Novartis Pharma AG, Basel, Switzerland
[21] Univ Liverpool, Inst Life Course & Med Sci, Liverpool, Merseyside, England
基金
美国国家卫生研究院;
关键词
chronic obstructive pulmonary disease; early COPD; FEV1; lung function; quantitative computed tomography; AIR-FLOW OBSTRUCTION; CHRONIC MUCUS HYPERSECRETION; COMPUTED-TOMOGRAPHY; NATURAL-HISTORY; DISEASE; EMPHYSEMA; STANDARDIZATION; ASSOCIATION; PHENOTYPE; UPDATE;
D O I
10.1164/rccm.202307-1203OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Chronic obstructive pulmonary disease (COPD) due to tobacco smoking commonly presents when extensive lung damage has occurred. Objectives: We hypothesized that structural change would be detected early in the natural history of COPD and would relate to loss of lung function with time. Methods: We recruited 431 current smokers (median age, 39 yr; 16 pack-years smoked) and recorded symptoms using the COPD Assessment Test (CAT), spirometry, and quantitative thoracic computed tomography (QCT) scans at study entry. These scan results were compared with those from 67 never-smoking control subjects. Three hundred sixty-eight participants were followed every six months with measurement of postbronchodilator spirometry for a median of 32months. The rate of FEV1 decline, adjusted for current smoking status, age, and sex, was related to the initial QCT appearances and symptoms, measured using the CAT. Measurements and Main Results: There were no material differences in demography or subjective CT appearances between the young smokers and control subjects, but 55.7% of the former had CAT scores greater than 10, and 24.2% reported chronic bronchitis. QCT assessments of disease probability-defined functional small airway disease, ground-glass opacification, bronchovascular prominence, and ratio of small blood vessel volume to total pulmonary vessel volume were increased compared with control subjects and were all associated with a faster FEV1 decline, as was a higher CAT score. Conclusions: Radiological abnormalities on CT are already established in young smokers with normal lung function and are associated with FEV1 loss independently of the impact of symptoms. Structural abnormalities are present early in the natural history of COPD and are markers of disease progression.
引用
收藏
页码:1208 / 1218
页数:11
相关论文
共 50 条
  • [21] Predicting an accelerated lung function decline in smokers: is there a proper threshold?
    Akkermans, Reinier P.
    Biermans, Marion
    Robberts, Bas
    ter Riet, Gerben
    Jacobs, Annelies
    van Weel, Chris
    Wensing, Michel
    Schermer, Tjard
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (01) : 308 - 309
  • [22] Clinical and Radiologic Disease in Smokers With Normal Spirometry
    Regan, Elizabeth A.
    Lynch, David A.
    Curran-Everett, Douglas
    Curtis, Jeffrey L.
    Austin, John H. M.
    Grenier, Philippe A.
    Kauczor, Hans-Ulrich
    Bailey, William C.
    Demeo, Dawn L.
    Casaburi, Richard H.
    Friedman, Paul
    Van Beek, Edwin J. R.
    Hokanson, John E.
    Bowler, Russell P.
    Beaty, Terri H.
    Washko, George R.
    Han, MeiLan K.
    Kim, Victor
    Kim, Song Soo
    Yagihashi, Kunihiro
    Washington, Lacey
    McEvoy, Charlene E.
    Tanner, Clint
    Mannino, David M.
    Make, Barry J.
    Silverman, Edwin K.
    Crapo, James D.
    JAMA INTERNAL MEDICINE, 2015, 175 (09) : 1539 - 1549
  • [23] Chronic viral hepatitis accelerates lung function decline in smokers
    Lee, Suh-Young
    Kim, Sun-Sin
    Lee, So-Hee
    Park, Heung-Woo
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2159 - 2165
  • [24] Interstitial Lung Abnormalities, Emphysema, and Spirometry in Smokers
    Menon, Aravind A.
    Putman, Rachel K.
    Sanders, Jason L.
    Hino, Takuya
    Hata, Akinori
    Nishino, Mizuki
    Ghosh, Auyon J.
    Ash, Samuel Y.
    Rosas, Ivan O.
    Cho, Michael H.
    Lynch, David A.
    Washko, George R.
    Silverman, Edwin K.
    Hatabu, Hiroto
    Hunninghake, Gary M.
    CHEST, 2022, 161 (04) : 999 - 1010
  • [25] COPD Assessment Test (CAT) Score according to the presence/absence of accelerated lung function decline in young adult smokers with normal FEV1
    Braddy-Green, Aaron
    Ritchie, Andrew I.
    Mah, Jordina
    Wiseman, Dexter J.
    Macleod, Mairi A.
    Allinson, James P.
    Donaldson, Gavin C.
    Bloom, Chloe
    Bolton, Charlotte
    Choudhury, Gourab
    Alves-Moreira, Luana
    Mcgarvey, Lorcan
    Sapey, Elizabeth
    Stockley, Robert
    Singh, Dave
    Wilkinson, Tom
    Fageras, Malin
    Ostridge, Kristoffer
    Jons, Olaf
    Bucchioni, Enrica
    Compton, Chris
    Jones, Paul
    Mezzi, Karen
    Vestbo, Jorgen
    Calverley, Peter Ma
    Wedzicha, Jadwiga A.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [26] Predictors for pulmonary function decline in interstitial lung disease
    Eisa, S.
    Rabbani, S.
    Podlasek, A.
    Sankar, S.
    Audet, S.
    Pattapola, S.
    Suthar, K.
    Ansari, S.
    Koduri, Gouri M.
    RHEUMATOLOGY, 2024, 63
  • [27] Predictors of decline in renal function after lung transplantation
    Barraclough, Kathryn
    Menahem, Solomon A.
    Bailey, Michael
    Thomson, Napier M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (12): : 1431 - 1435
  • [28] PREDICTORS FOR PULMONARY FUNCTION DECLINE IN INTERSTITIAL LUNG DISEASE
    Eisa, S.
    Rabbani, S.
    Podlasek, A.
    Sankar, S.
    Audet, S.
    Pattapola, S.
    Suthar, K.
    Ansari, S.
    Koduri, Gouri M.
    RHEUMATOLOGY, 2024, 63 : I140 - I140
  • [29] LUNG CLEARANCE INDEX (LCI) IS A SENSITIVE MARKER OF EARLY AIRWAY CHANGES IN SMOKERS WITH NORMAL SPIROMETRY
    Bell, N. J.
    Horsley, A. R.
    Reid, P. A.
    Sheridan, H. S.
    Monaghan, M.
    Connelly, H.
    Greening, A. P.
    Innes, J. A.
    THORAX, 2010, 65 : A132 - A133
  • [30] Health status impact on mortality and lung function decline in COPDGene smokers
    Labaki, Wassim
    Gu, Tian
    Murray, Susan
    Curtis, Jeffrey
    Soler, Xavier
    Bhatt, Surya
    Bon, Jessica
    Beaty, Terri
    Hokanson, John
    Curran-Everett, Douglas
    Lowe, Katherine
    Bowler, Russell
    Make, Barry
    Regan, Elizabeth
    Martinez, Fernando
    Hersh, Craig
    Silverman, Edwin
    Crapo, James
    Han, Meilan
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54